The Zambia Medicines and Medical Supplies Agency (ZAMMSA) is pleased to announce that the country maintains a robust supply of Anti-Retroviral (ARV) drugs to meet patient demand.
Currently, we have over six months’ supply of first, second, and third-line ARV drugs, ensuring that all patients undergoing Anti-Retroviral Treatment (ART) receive their necessary medications without interruption. 
In light of recent concerns, ZAMMSA assures the public that there is no current or impending shortage of ARVs. We encourage everyone to remain calm, as the supply and distribution of this essential medication is stable.
Healthcare facilities that may have experienced temporary shortages are urged to submit emergency orders for restocking to ensure uninterrupted services to the community.
ZAMMSA is committed to the efficient procurement, storage, and distribution of vital health commodities. Our ongoing efforts are focused on ensuring that every citizen has equitable access to essential medical supplies, contributing to a healthier and more productive Zambia.
